Elanco Animal Health Incorporated (ELAN): Price and Financial Metrics
Elanco Animal Health Incorporated (ELAN)
Today's Latest Price: $31.13 USD
Updated Oct 28 10:32am
Add ELAN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ELAN Stock Summary
- ELAN has a higher market value than 86.2% of US stocks; more precisely, its current market capitalization is $12,298,160,499.
- ELAN's went public 2.1 years ago, making it older than only 4.35% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for ELAN is currently 37.32, higher than 90.15% of US stocks with positive operating cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to Elanco Animal Health Inc are OTEX, OPK, LIVN, JAZZ, and LFUS.
- ELAN's SEC filings can be seen here. And to visit Elanco Animal Health Inc's official web site, go to www.elanco.com.
ELAN Stock Price Chart Interactive Chart >
ELAN Price/Volume Stats
| Current price | $31.13 | 52-week high | $34.09 |
| Prev. close | $31.55 | 52-week low | $15.17 |
| Day low | $30.79 | Volume | 225,398 |
| Day high | $31.49 | Avg. volume | 5,070,425 |
| 50-day MA | $28.92 | Dividend yield | N/A |
| 200-day MA | $25.36 | Market Cap | 12.42B |
Elanco Animal Health Incorporated (ELAN) Company Bio
Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.
ELAN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $31.13 | $3.96 | -87% |
Below please find a table outlining a discounted cash flow forecast for ELAN, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Elanco Animal Health Inc ranked in the 13th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Elanco Animal Health Inc ended up being:
- Elanco Animal Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 42 -- greater than 93.25% of US stocks with positive free cash flow.
- Elanco Animal Health Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -1.05. This coverage rate is greater than that of just 19.9% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- The weighted average cost of capital for the company is 10. This value is greater than 78.43% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -87% |
| 1% | -87% |
| 2% | -87% |
| 3% | -87% |
| 4% | -87% |
| 5% | -87% |
Want more companies with a valuation profile/forecast similar to that of Elanco Animal Health Inc? See BSX, TECH, LMNX, PCRX, and TEVA.
Loading social stream, please wait...